enGene Therapeutics (ENGN) Selling, General & Administrative (2023 - 2026)
enGene Therapeutics (ENGN) posted Selling, General & Administrative of $13.92 million for fiscal Q3 2026 (quarter ended Jul 31, 2026), up 88.9% from $7.37 million a year earlier and up 42.5% from the prior quarter.
enGene Therapeutics (ENGN) Selling, General & Administrative (2023 - 2026) Analysis & Trends
For the trailing twelve months through Jul 31, 2026, Selling, General & Administrative at enGene Therapeutics was $40.39 million, up 49.0% year-over-year; for FY2025 (ended Oct 31, 2025), it was $28.69 million, up 19.6% from FY2024.
- Annual Selling, General & Administrative has increased for three consecutive fiscal years, with a three-year compound annual growth rate of 93.5% (FY2022 to FY2025).
- In prior fiscal years, enGene Therapeutics' Selling, General & Administrative was $23.98 million in FY2024 (+149.8%), $9.6 million in FY2023 (+142.5%) and $3.96 million in FY2022.
- The fiscal Q3 2026 figure stands as the highest quarterly Selling, General & Administrative in data going back to fiscal Q1 2023.
- On a year-over-year basis, Selling, General & Administrative has increased in each of the last five quarters, with growth averaging 35.4% over the last eight quarters.
- The strongest year-over-year quarter for Selling, General & Administrative in the past five years was fiscal Q1 2024, with growth of 433.8%; the weakest was fiscal Q2 2025, with a decline of 7.2%.
- According to Business Quant data, Selling, General & Administrative for the three prior fiscal quarters was $9.77 million (Q2 2026), $8.93 million (Q1 2026) and $7.76 million (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 3.43 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 6.43 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 3.63 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 2.90 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | -3.24 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | -5.65 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 1.75 Bn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | 1.92 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 3.41 Bn |
| 10 | enGene Therapeutics | 132.69 Mn | 132.69 Mn | - | 13.92 Mn |
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | 13.92 Mn |
| Apr 30, 2026 | 9.77 Mn |
| Jan 31, 2026 | 8.93 Mn |
| Oct 31, 2025 | 7.76 Mn |
| Jul 31, 2025 | 7.37 Mn |
| Apr 30, 2025 | 6.92 Mn |
| Jan 31, 2025 | 6.64 Mn |
| Oct 31, 2024 | 6.18 Mn |
| Jul 31, 2024 | 5.21 Mn |
| Apr 30, 2024 | 7.46 Mn |
| Jan 31, 2024 | 5.14 Mn |
| Oct 31, 2023 | 4.77 Mn |
| Jul 31, 2023 | 2.35 Mn |
| Apr 30, 2023 | 1.52 Mn |
| Jan 31, 2023 | 962,000.00 |
enGene Therapeutics Selling, General & Administrative API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=ENGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "selling-general-and-administrative", "ticker": "ENGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=ENGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();